Should I invest in UTI Focused Fund?

We don't give personal investment advice. UTI Focused Fund - Regular Plan - Growth Option is suitable for an investor whose:time horizon is **5+ years** — equity funds can drop 30-50% in bad years; horizons under 5 years materially raise the risk of selling at a lossrisk tolerance accepts seeing the portfolio fall sharply without panic-sellinggoal isn't capital preservation in the short termCross-check the numbers above against alternatives before deciding. 5-year CAGR: 8.90%.

UTI

UTI Focused Fund - Regular Plan - Growth Option

Latest NAV

₹15.3215

As of

17 Jul 2026

1,204 NAV records on file

NAV history & peer comparison

All NAVs split-adjusted and normalised to 100 at the start of the selected period, so funds with very different absolute NAV scales can be compared on one axis.

Period

Add another fund to compare

No matches.

Compares up to 8 funds. Click any line in the legend above to hide/show it.

Returns matrix

Fund return alongside the category average and peer rank for every standard window. Returns under one year are absolute; one year and longer are compound annualised (CAGR).

Window	Fund	Category avg	+/− vs avg	Rank	Quartile
1D	+0.81%	+0.28%	+0.53	2 / 18	Q1
1W	+0.27%	-0.15%	+0.41	4 / 18	Q1
2W	+0.49%	+0.26%	+0.23	8 / 18	Q2
1M	+2.01%	+1.99%	+0.01	10 / 18	Q3
3M	+2.01%	+4.43%	-2.42	13 / 18	Q3
6M	-2.36%	+2.25%	-4.61	15 / 18	Q4
YTD	-3.64%	+0.57%	-4.21	15 / 18	Q4
1Y	-1.24%	+1.60%	-2.85	13 / 18	Q3
2Y	-0.97%	+1.73%	-2.70	16 / 18	Q4
3Y	+10.22%	+12.29%	-2.07	13 / 17	Q4
4Y	+12.44%	+13.81%	-1.37	12 / 15	Q4
5Y	+8.90%	+11.10%	-2.21	11 / 13	Q4
7Y	—	—	—	—	—
10Y	—	—	—	—	—
Inception	+9.10%	+13.86%	-4.76	17 / 18	Q4

Quartile legend: Q1 top 25% Q2 25-50% Q3 50-75% Q4 bottom 25%

Calendar-year returns

Full-year performance vs category average. Current year is partial (year-to-date).

Year	Fund	Category avg	+/− vs avg	Rank
2026 YTD	-3.64%	+0.57%	-4.21	15 / 18
2025	+6.10%	+3.22%	+2.87	6 / 18
2024	+12.89%	+19.16%	-6.27	16 / 17
2023	+28.36%	+25.63%	+2.74	7 / 15
2022	-0.40%	-1.51%	+1.11	7 / 13
2021	—	—	—	—

Rolling returns

Removes start-date bias by averaging CAGR over every overlapping N-year window in the fund's history. Higher average plus tight min/max plus high "% positive" = consistent.

1-Year rolling

+13.01%

48 windows

min -6.0% · max 43.1%

79% positive

Limited basis — fund is young, so this average may be skewed by which 1Y windows happen to be available.

3-Year rolling

+14.88%

24 windows

min 10.2% · max 19.7%

100% positive

Limited basis — fund is young, so this average may be skewed by which 3Y windows happen to be available.

5-Year rolling

—

Insufficient history

7-Year rolling

—

Insufficient history

SIP returns — historical "what if"

If you had invested every month in this fund over the chosen period, this is what your investment would be worth today.

Period

Total invested

₹ —

Today's value

₹ —

XIRR

Annualised

Wealth multiplier

Period	Total invested	Today's value	XIRR	Wealth multiplier

XIRR is the annualised internal rate of return on the SIP cash flow — invariant to the monthly amount. "Today's value" and "Total invested" scale linearly with the slider. Past performance does not guarantee future returns. Excludes exit load and taxes.

Risk profile

Risk-adjusted return and volatility, computed from monthly NAV returns over the trailing 3-year and 5-year windows.

Std deviation

12.84%

3-year · annualised

Sharpe ratio

0.31

vs risk-free 6.5%

Sortino ratio

0.48

Downside-only deviation

Max drawdown

-19.77%

Sep 2024 → Mar 2026

% positive months

66.7%

Share of monthly returns > 0 over the 3-year window

Sharpe / Sortino use a risk-free rate of 6.5% (1-year T-bill proxy). Higher Sharpe = more return per unit of total risk; higher Sortino = more return per unit of downside risk.

Peers in Focused Fund

Scheme	Fund house	NAV	As of
Invesco India Focused Fund - Regular Plan - Growth	Invesco	₹28.8700	17 Jul 2026
Motilal Oswal Focused Fund - Regular Plan Growth Option	Motilal Oswal	₹49.5132	17 Jul 2026
Mirae Asset Focused Fund Regular Plan Growth	Mirae Asset	₹24.5940	17 Jul 2026
Kotak Focused Fund- Regular plan _ Growth Option	Kotak	₹27.4700	17 Jul 2026
Edelweiss Focused Fund - Regular Plan - Growth	Edelweiss	₹16.5010	17 Jul 2026
DSP Focused Fund - Regular Plan - Growth	DSP	₹55.7180	17 Jul 2026
HSBC Focused Fund - Regular Growth	HSBC	₹26.4744	17 Jul 2026
BARODA BNP PARIBAS Focused Fund - Regular Plan-Growth Option	Baroda BNP Paribas	₹21.0089	17 Jul 2026
Canara Robeco Focused Fund - Regular Plan - Growth Option	Canara Robeco	₹19.6500	17 Jul 2026
Axis Focused Fund - Regular Plan - Growth Option	Axis	₹54.2600	17 Jul 2026

Recent NAVs

Date	NAV
17 Jul 2026	₹15.3215
16 Jul 2026	₹15.1982
15 Jul 2026	₹15.2415
14 Jul 2026	₹15.1859
13 Jul 2026	₹15.2773
10 Jul 2026	₹15.2808
9 Jul 2026	₹15.1337
8 Jul 2026	₹15.0535
7 Jul 2026	₹15.3495
6 Jul 2026	₹15.3372

Frequently asked questions

These answers are generated from this fund's live metrics — NAV, returns, peer rank, drawdown, SIP backtest. Numbers refresh nightly after AMFI's NAV feed lands.

As of 17 Jul 2026, the NAV of UTI Focused Fund - Regular Plan - Growth Option is ₹15.3215. It's a Focused Fund from UTI, run as a Regular plan Growth option. NAVs update once per business day from the AMFI feed.

UTI Focused Fund - Regular Plan - Growth Option has NAV history starting from 26 Aug 2021, a track record of about 4 years 10 months. It's a relatively new scheme. With under 5 years of NAVs, peer comparison is the best yardstick — point-to-point returns can be skewed by entry timing.

UTI Focused Fund - Regular Plan - Growth Option is managed by UTI. It's classified by AMFI under the 'Focused Fund' SEBI category, which determines its peer set and tax treatment.

Over the trailing 1-year window, UTI Focused Fund - Regular Plan - Growth Option has delivered a absolute return of -1.24% — -2.85 pp behind the Focused Fund category average of 1.60%. The fund ranks #13 of 18 in its category — the third (Q3) quartile.

Over the trailing 3-year window, UTI Focused Fund - Regular Plan - Growth Option has delivered a CAGR of 10.22% — -2.07 pp behind the Focused Fund category average of 12.29%. The fund ranks #13 of 17 in its category — the bottom (Q4) quartile.

Over the trailing 5-year window, UTI Focused Fund - Regular Plan - Growth Option has delivered a CAGR of 8.90% — -2.21 pp behind the Focused Fund category average of 11.10%. The fund ranks #11 of 13 in its category — the bottom (Q4) quartile.

₹1 lakh invested in UTI Focused Fund - Regular Plan - Growth Option exactly 5 years ago would be worth approximately ₹153,130 today — a multiplier of 1.53×, based on the 5-year CAGR of 8.90%. The category average over the same window would have grown ₹1 lakh to ₹169,304.

A ₹10,000 monthly SIP in UTI Focused Fund - Regular Plan - Growth Option over the last 3 years — total invested ₹360,000 — would be worth ₹385,099 today. That's an XIRR (money-weighted annualised return) of 4.42%.

UTI Focused Fund - Regular Plan - Growth Option doesn't yet have 10 years of NAVs. Over the longest available window (3-year SIP), ₹10,000/month would have grown to ₹385,099 — XIRR 4.42%.

On a 5-year basis, UTI Focused Fund - Regular Plan - Growth Option ranks #11 out of 13 funds in the Focused Fund category — that places it in the bottom quartile (Q4) — material underperformance. The category average return over the same window is 11.10%; this fund delivered 8.90%.

The worst peak-to-trough decline UTI Focused Fund - Regular Plan - Growth Option has experienced over the last 3-year window is 19.77% — its NAV fell from a high on 26 Sep 2024 to a low on 31 Mar 2026. Drawdown is a useful gauge of how much short-term pain you'd have endured to capture the long-term return.

Across all 3-year rolling windows, UTI Focused Fund - Regular Plan - Growth Option averaged 14.88% (best 19.72%, worst 10.22%). 100% of rolling windows ended positive. The 3-year Sharpe ratio is 0.31 — weak risk-adjusted performance.

In calendar year 2025, UTI Focused Fund - Regular Plan - Growth Option returned 6.10% — beating the Focused Fund category average of 3.22% by 2.87 pp. It ranked #6 of 18 in its category that year.

UTI Focused Fund - Regular Plan - Growth Option is classified as an Equity fund (at least 65% equity exposure). Tax rules (post Budget 2024): if you hold 12 months or more, gains are Long-Term and taxed at 12.5% on the amount exceeding ₹1.25 lakh per financial year. Held for under 12 months, gains are Short-Term and taxed at 20%. The ₹1.25 L exemption is per PAN per FY across all equity LTCG.

We don't give personal investment advice. UTI Focused Fund - Regular Plan - Growth Option is suitable for an investor whose:

time horizon is **5+ years** — equity funds can drop 30-50% in bad years; horizons under 5 years materially raise the risk of selling at a loss
risk tolerance accepts seeing the portfolio fall sharply without panic-selling
goal isn't capital preservation in the short term

Cross-check the numbers above against alternatives before deciding. 5-year CAGR: 8.90%.

Educational content only — not investment advice. Tax rules summarised above reflect Budget 2024; consult a qualified adviser before transacting.